DCF — ENGLEWOOD HOSPITAL & MED CTR
Enterprise Value: $-192.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-192.9M
Enterprise Value
$-86.6M
PV of Cash Flows
$-106.3M
PV of Terminal Value
$-171.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $996.3M | $5.7M | 1.0% | $-36.5M | $-33.2M |
| Year 2 | $1.0B | $16.1M | 2.0% | $-27.3M | $-22.6M |
| Year 3 | $1.1B | $27.2M | 3.0% | $-17.8M | $-13.3M |
| Year 4 | $1.1B | $33.4M | 3.0% | $-14.2M | $-9.7M |
| Year 5 | $1.1B | $37.2M | 3.0% | $-12.5M | $-7.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-192.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$967.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0007059449860166364
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5